Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03541928
Title Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors The Methodist Hospital System

prostate adenocarcinoma


Bicalutamide + HSV-Tk + Leuprolide + Valacyclovir

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.